Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 NanoViricides Appoints Id3A for cGMP Facility | Contract Pharma

What are you searching for?

Sign in
Breaking News

NanoViricides Appoints Id3A for cGMP Facility

Will be responsible for architecture and integration of clean room suite

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

NanoViricides, Inc. has retained Id3A, LLC as the architect for its lab and cGMP pilot production facility. The facility will be built by renovating an existing 18,000-sq.-ft. light manufacturing plant in Shelton, CT. The cGMP pilot plant is being designed for the production of sufficient quantities of the drug needed for human clinical trials for each of the various nanoviricides drug candidates entering trials.
 
Kathyann Cowles, AIA, will serve as the principal architect for the project. Id3A will be responsible for the overall facility architecture, including integration of a separately constructed clean room suite for cGMP production. Ms. Cowles will join Andrew Hahn and Phil Mader of MPH Engineering, LLC on the architecture, design and construction management team.
 
Prior to founding Id3A, Ms. Cowles worked on a variety of projects in the Pharma, Medical, Academic, and Science sectors, including Chemistry and Biology (BL4) Lab Renovations, an MRI Suite, and CADD and SATT Lab projects at Bristol-Myers-Squibb in Wallingford, CT.
 
“Ms. Cowles has a unique ability to work with clients in meeting complex and detailed requirements,” said Anil R. Diwan, Ph.D., president of the company, adding, “This is critically important for our challenging project that specifies not only state-of-the-art facility requirements, but also cost sensitivity, space efficiency, and a high degree of energy efficiency.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics